Aims: The aim of this study was to determine the treatment outcome of spider naevi using pulse dye laser (PDL) therapy. Results: There was improvement seen in all patients with complete resolution in 31 patients (76%) and 67 lesions (82%).
Introduction
Spider naevi are benign cutaneous vascular lesions that involve a group of pulsatile and dilated arterioles. The collection of these vessels has a centre that blanches when pressure is applied to its centre. 1 These lesions are common and occur in 15 percent of children and adults. 2 Although they are harmless, they may cause significant cosmetic problems. They commonly appear on exposed areas such as the face, upper trunk and upper limbs [2] [3] [4] [5] and less commonly on the lower limbs and lower trunk. 4 Various treatment modalities such as electrocautery, sclerotherapy and laser therapy have been used for spider naevi. Electrocautery may be associated with excessive bleeding and scarring. Older lasers, including the argon laser, have been associated with an unacceptably high incidence of scarring and pigmentary changes. 2 Previous reports 2, 5 show effectiveness of PDL on spider naevi however, follow up has been limi-ted. The aim of this study was to determine the treatment outcome of spider naevi using pulse PDL.
Patients and Methods
This was a retrospective study which reviewed consecutive patients undergoing PDL for spider naevi at our laser service between 15 October 2003 and 19 August 2008.
The patients were culled from our prospective laser database and information was supplemented by review of the medical records. The information collected was of the age, sex, number and location of the lesions, the number of treatment sessions for each patient.
PDL treatment was carried out as an outpatient procedure using the Candela V Beam with a dynamic cooling device (set at 30/30) using fluences of 10.5 joules/cm2 and 1.5msec using a 7mm hand piece. An additional pulse of 15 joules/cm2 at 6msec using 5mm hand piece to lesions with a raised centre. The number of pulses depended on the size of lesions overlapped by 1mm.
A questionnaire was dispatched to adult patients and the parents of children on previous treatments, outcomes, recurrence, side effects and satisfaction. Those who had not responded within four weeks were telephoned and the questionnaire was completed.
Data were entered into a Microsoft Excel spreadsheet and analysed.
Results
49 patients aged 7 months to 63 years (mean, 21 years) with 76 (mean, 1.6; range 1-5) spider naevi were treated with PDL. 39 (80%) patients were females. The lesions were located on the face (n=65) and upper limbs (n=11). Eight (20%) patients had previous unsuccessful treatment to PDL with liquid nitrogen (n=2) and, electrocautery (n=5) and topical cream (n=1).
41 (84%) patients completed and returned the questionnaire. The average follow-up period was 46 (range, 15-66) months. 28 patients were contacted by phone and completed the questionnaires. Eight patients were not contactable.
Complete resolution of the lesions occurred in 31 patients (76%) with 67 lesions (82%). Out of these, 25 patients (81%) with 45 lesions (67%) resolved completely after only one treatment. Three patients with seven lesions (10%) required two treatments. One with one lesion (1.5%) underwent three treatments. One with one lesion (1.5%) had four and one with one lesion (1.5%) had eight.
10 patients (24%) had partial resolution. Two patients moved cities during treatment and had not completed their treatment course.
Six out of the eight patients who had previous treatment had complete resolution whilst the two who had electrocautery before had partial resolution.
Two patients (4.9%) with a total of four lesions developed recurrence in two lesions only.
Five patients developed temporary hyperpigmentation and one patient experienced hypopigmentation.
30 of the 41 responders (73%) were very satisfied and six (15%) were satisfied with the result. One patient of the 41 responders (2.4%) who was very dissatisfied did not complete the treatment as she had relocated cities following two treatments. She recommended the treatment for others and stated she would like to come back for further treatment.
Another patient who developed a partial recurrence one year following treatment was dissatisfied with the outcome.
38 patients out of 41 (93%) would recommend the treatment to others. Two patients (4.9%) said they did not know and one (2.4%) said no.
Discussion
This study shows an overall satisfactory response to PDL with complete eradication of spider naevi in 76% of cases with 55 lesions (82%) with a recurrence in 6.5% of patients and 3.6% of lesions with an average of 3.5 years follow up. Most patients would recommend PDL to others. Side effects were usually mild and temporary and this reflected the selectivity of PDL in targeting vascular structures and preventing damage to surrounding structures. 2 
Conclusion
To our knowledge this is the largest study on spider naevi treated with PDL in terms of number of patients and also the longest follow-up period.
PDL is effective and safe for the treatment of spider naevi.
